3SBio Buys Back 1.00 Million Shares for HKD 14.80 Million, Treasury Stock Rises to 23.98 Million

Bulletin Express

Oct 12

On 12 October 2026, Hong Kong–listed biopharmaceutical firm 3SBio Inc. executed an on-market repurchase of 1.00 million ordinary shares at prices ranging between HKD 14.70 and HKD 14.90, with a volume-weighted average cost of HKD 14.80 per share. The transaction totalled HKD 14.80 million.

Following the buyback, the company’s issued share capital (excluding treasury shares) decreased by 0.04 % to 2.514 billion shares, while treasury shares rose to 23.98 million. The total number of issued shares, inclusive of treasury stock, remained unchanged at 2.538 billion.

The repurchase forms part of the authority granted by shareholders on 25 June 2026, which allows 3SBio to repurchase up to 253.71 million shares. Cumulative purchases under this mandate now stand at 22.96 million shares, equivalent to 0.91 % of the company’s issued share count on the mandate date.

As stipulated by Hong Kong Stock Exchange rules, 3SBio is subject to a moratorium on new share issues or the sale/transfer of treasury shares until 11 November 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au.tigermarketd.com/news/1125843351"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1125843351\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1125843351?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-10-12 18:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1125843351","market":"us","top_or_hot":-1,"title":"3SBio Buys Back 1.00 Million Shares for HKD 14.80 Million, Treasury Stock Rises to 23.98 Million","media":"Bulletin Express","content":"<p>On 12 October 2026, Hong Kong–listed biopharmaceutical firm 3SBio Inc. executed an on-market repurchase of 1.00 million ordinary shares at prices ranging between HKD 14.70 and HKD 14.90, with a volume-weighted average cost of HKD 14.80 per share. The transaction totalled HKD 14.80 million.</p>\n<p>Following the buyback, the company’s issued share capital (excluding treasury shares) decreased by 0.04 % to 2.514 billion shares, while treasury shares rose to 23.98 million. The total number of issued shares, inclusive of treasury stock, remained unchanged at 2.538 billion.</p>\n<p>The repurchase forms part of the authority granted by shareholders on 25 June 2026, which allows 3SBio to repurchase up to 253.71 million shares. Cumulative purchases under this mandate now stand at 22.96 million shares, equivalent to 0.91 % of the company’s issued share count on the mandate date.</p>\n<p>As stipulated by Hong Kong Stock Exchange rules, 3SBio is subject to a moratorium on new share issues or the sale/transfer of treasury shares until 11 November 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3SBio Buys Back 1.00 Million Shares for HKD 14.80 Million, Treasury Stock Rises to 23.98 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3SBio Buys Back 1.00 Million Shares for HKD 14.80 Million, Treasury Stock Rises to 23.98 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-10-12 18:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On 12 October 2026, Hong Kong–listed biopharmaceutical firm 3SBio Inc. executed an on-market repurchase of 1.00 million ordinary shares at prices ranging between HKD 14.70 and HKD 14.90, with a volume-weighted average cost of HKD 14.80 per share. The transaction totalled HKD 14.80 million.</p>\n<p>Following the buyback, the company’s issued share capital (excluding treasury shares) decreased by 0.04 % to 2.514 billion shares, while treasury shares rose to 23.98 million. The total number of issued shares, inclusive of treasury stock, remained unchanged at 2.538 billion.</p>\n<p>The repurchase forms part of the authority granted by shareholders on 25 June 2026, which allows 3SBio to repurchase up to 253.71 million shares. Cumulative purchases under this mandate now stand at 22.96 million shares, equivalent to 0.91 % of the company’s issued share count on the mandate date.</p>\n<p>As stipulated by Hong Kong Stock Exchange rules, 3SBio is subject to a moratorium on new share issues or the sale/transfer of treasury shares until 11 November 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01530","symbol_name":"三生制药","start_time":0,"source_url":"","article_id":"1125843351","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1125843351","pubTimestamp":1791801695,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"On 12 October 2026, Hong Kong–listed biopharmaceutical firm 3SBio Inc. executed an on-market repurchase of 1.00 million ordinary shares at prices ranging between HKD 14.70 and HKD 14.90, with a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01530":"三生制药"},"translate_title":"三生制药1480万港元回购100万股，库存股增至2398万股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01530":1},"content_text":"On 12 October 2026, Hong Kong–listed biopharmaceutical firm 3SBio Inc. executed an on-market repurchase of 1.00 million ordinary shares at prices ranging between HKD 14.70 and HKD 14.90, with a volume-weighted average cost of HKD 14.80 per share. The transaction totalled HKD 14.80 million.\nFollowing the buyback, the company’s issued share capital (excluding treasury shares) decreased by 0.04 % to 2.514 billion shares, while treasury shares rose to 23.98 million. The total number of issued shares, inclusive of treasury stock, remained unchanged at 2.538 billion.\nThe repurchase forms part of the authority granted by shareholders on 25 June 2026, which allows 3SBio to repurchase up to 253.71 million shares. Cumulative purchases under this mandate now stand at 22.96 million shares, equivalent to 0.91 % of the company’s issued share count on the mandate date.\nAs stipulated by Hong Kong Stock Exchange rules, 3SBio is subject to a moratorium on new share issues or the sale/transfer of treasury shares until 11 November 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}